Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.61 |
| ▸ | FAAH | O00519 | 5/20 | 0.55 |
| ▸ | CES1 | P23141 | 5/20 | 0.48 |
| ▸ | CES2 | O00748 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | XBP1 | P17861 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9423619 | 0.97 | CA2 (0.65) | CA2FAAHCES1CES2 | |
| SCHEMBL8778698 | 0.97 | CA2 (0.65) | CA2FAAHCES1CES2 | |
| SCHEMBL8778743 | 0.97 | CA2 (0.65) | CA2FAAHCES1CES2 | |
| SCHEMBL8778867 | 0.97 | CA2 (0.65) | CA2FAAHCES1CES2 | |
| SCHEMBL8778804 | 0.97 | CA2 (0.65) | CA2FAAHCES1CES2 | |
| SCHEMBL9941 | 0.97 | CA2 (0.64) | CA2FAAHCES1CES2ESR1 | |
| Fluoride SCHEMBL25435314 | 0.94 | CA2 (0.61) | CA2FAAHCES1CES2ESR1 | |
| SCHEMBL350042 | 0.94 | CA2 (0.68) | CA2FAAHCES1CES2 | |
| SCHEMBL395321 | 0.94 | CA2 (0.68) | CA2FAAHCES1CES2 | |
| SCHEMBL5586100 | 0.94 | CA2 (0.68) | CA2FAAHCES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | claimed |
| CN-106165043-B | Electrochemical device electrolyte solvent | 住友精化株式会社 | 2019-03-26 | — | — | CN | disclosed |
| EP-3133623-B1 | SOLVENT FOR ELECTROLYTIC SOLUTION FOR USE IN ELECTROCHEMICAL DEVICES | SUMITOMO SEIKA CHEMICALS (JP) | 2018-11-21 | — | — | EP | disclosed |
| US-20170098859-A1 | SOLVENT FOR ELECTROLYTIC SOLUTION FOR USE IN ELECTROCHEMICAL DEVICES | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2017-04-06 | — | — | US | disclosed |
| EP-3133623-A1 | SOLVENT FOR ELECTROLYTIC SOLUTION FOR USE IN ELECTROCHEMICAL DEVICES | Sumitomo Seika Chemicals Co., Ltd. (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-6809206-B2 | CONTACTING A PHENYL ESTER COMPOUND WITH A CYCLIC COMPOUND IN THE PRESENCE OF A SOURCE OF CYANIDE OR FLUORIDE TO PREPARE ACYLATED CYCLIC 1,3-DICARBONYL COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-10-26 | — | — | US | disclosed |
| US-20030232984-A1 | Method for acylating cyclic compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-12-18 | — | — | US | disclosed |
| EP-0602914-B1 | Ink compositions for ink jet printing | XEROX CORP (US) | 1997-11-12 | — | — | EP | disclosed |
| EP-0449296-B1 | Palladium catalyzed carboalkoxylation of butadiene | DU PONT (US) | 1994-09-14 | — | — | EP | disclosed |
| EP-0602914-A1 | Ink compositions for ink jet printing | XEROX CORPORATION (US) | 1994-06-22 | — | — | EP | disclosed |
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | disclosed |
| US-5160414-A | A thiophene, 1,1-dioxide as solvent | PHILLIPS PETROLEUM COMPANY (US) | 1992-11-03 | — | — | US | disclosed |
| EP-0449296-A1 | Palladium catalyzed carboalkoxylation of butadiene | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-02 | — | — | EP | disclosed |
| US-5026901-A | Producing alkyl pentenoate | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232984-A1 | Method for acylating cyclic compounds | LCAT, ACOT7, AGPAT5 | CA2 227/4885FAAH 142/4885CES1 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.